MDT

96.22

-1.37%↓

A

147.04

-1.03%↓

VEEV

235.3

-1.81%↓

HQY

87.29

-7.42%↓

PHR.US

16.86

-1.81%↓

MDT

96.22

-1.37%↓

A

147.04

-1.03%↓

VEEV

235.3

-1.81%↓

HQY

87.29

-7.42%↓

PHR.US

16.86

-1.81%↓

MDT

96.22

-1.37%↓

A

147.04

-1.03%↓

VEEV

235.3

-1.81%↓

HQY

87.29

-7.42%↓

PHR.US

16.86

-1.81%↓

MDT

96.22

-1.37%↓

A

147.04

-1.03%↓

VEEV

235.3

-1.81%↓

HQY

87.29

-7.42%↓

PHR.US

16.86

-1.81%↓

MDT

96.22

-1.37%↓

A

147.04

-1.03%↓

VEEV

235.3

-1.81%↓

HQY

87.29

-7.42%↓

PHR.US

16.86

-1.81%↓

Home・Aandelen Lijst・Fortress Biotech Inc

Search

Fortress Biotech Inc

Open

3.95 -8.99

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

3.98

Max

4.34

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+145.43% upside

Dividenden
By Dow Jones
Volgende Winsten	27 mrt 2026

Fortress Biotech Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 dec 2025, 16:30 UTC

Belangrijke Marktbewegers

Fortress Biotech Rises After FDA Accepts Application for Menkes Treatment

1 okt 2025, 15:07 UTC

Belangrijke Marktbewegers

Fortress Biotech Shares Drop After FDA Letter for CUTX-101 Manufacturing Facility

10 mrt 2025, 02:12 UTC

Acquisities, Fusies, Overnames

Checkpoint Controlling Shareholder Fortress Has Agreed to Vote in Favor of Transaction >524715.BY

10 mrt 2025, 02:12 UTC

Acquisities, Fusies, Overnames

Sun Pharma, Checkpoint Transaction Expected to Complete in 2Q 2025 >524715.BY

10 mrt 2025, 02:11 UTC

Acquisities, Fusies, Overnames

Sun Pharma, Checkpoint, Fortress Biotech Enter Into Royalty Agreement >524715.BY

10 mrt 2025, 02:11 UTC

Acquisities, Fusies, Overnames

Checkpoint Shareholders Entitled to Receive Up to Additional $0.70 if Cosibelimab if Approved in EU Prior to Certain Deadlines >524715.BY

10 mrt 2025, 02:10 UTC

Acquisities, Fusies, Overnames

Checkpoint Shareholders to Receive Upfront Cash Payment of $4.10/Share, Contingent Value Right >524715.BY

10 mrt 2025, 02:10 UTC

Acquisities, Fusies, Overnames

Sun Pharma to Acquire Checkpoint Therapeutics >524715.BY CKPT

10 mrt 2025, 02:06 UTC

Acquisities, Fusies, Overnames

Sun Pharma To Acquire Checkpoint Therapeutics >524715.BY CKPT

Peer Vergelijking

Prijswijziging

Fortress Biotech Inc Prognose

Koersdoel

By TipRanks

145.43% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 10.75 USD 145.43%

Hoogste 17 USD

Laagste 4.5 USD

Gebaseerd op 2 Wall Street-analisten die 12-maands prijsdoelen bieden voor Fortress Biotech Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

2 ratings

2

Buy

0

Hold

0

Sell

Gebaseerd op 2 analisten die aandelenratings hebben gegeven aan Fortress Biotech Inc - Dist in de afgelopen 3 maanden.

Financieel

$

Andere aandelen uit de sector

MDT

Medtronic PLC

96.22

A

Agilent Technologies Inc

147.04

VEEV

Veeva Systems Inc

235.3

HQY

HealthEquity Inc

87.29

PHR.US

Phreesia Inc

16.86

Live chat